Sales of Facial Implant Is Expected to Rise At A 7.7% CAGR by 2032

The market for face implants was valued at US$ 2.7 billion globally in 2022 and is anticipated to grow at a value CAGR of 7.7%, potentially reaching US$ 5.6 billion by the end of the forecast period of 2022–2032. The market had a value of US$ 2.5 billion as of 2021, and in 2022 it grew by 8% year over year. One of the key factors anticipated to boost market expansion is the rise in congenital disorders causing facial abnormalities.

It is anticipated that the rising concern for one’s looks among the local population in both developed and developing nations would lead to more cosmetic procedures, which will in turn help the market grow. It is anticipated that virtual representation would increase on social fuel the demand for the facial implant market throughout the forecast period. Moreover, the growing concern regarding personal appearance among the local population in both developed and developing countries is projected to increase the number of cosmetic surgeries, which in turn is expected to propel the growth of the market.

Download a Sample Copy of This Report: 

Global Facial Implants Market: Segmentation

  • Facial Implant Market by Product :
    • Chin and Mandibular Implants
    • Cheek Implants
    • Nasal Implants
    • Facial Implant Injectables
  • Facial Implant Market by Material :
    • Metal Facial Implants
    • Biologicals Facial Implants
    • Polymers Facial Implants
    • Ceramic Facial Implants
  • Facial Implant Market by Procedure :
    • Facial Implants for Eyelid Surgery
    • Facial Implants for Facelift
    • Facial Implants for Rhinoplasty
  • Facial Implant Market by Region :
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

To make the Facial Implants market easier to grasp, analysts have divided it. Application, technology, and user variables have all been considered while segmenting the market. Graphs and pictures have been used to further illustrate each component. This market study offers a straightforward assessment of the worldwide Facial Implants market to help readers make wise investment choices.

We are aware that a geographic analysis is necessary for a market research study to be complete. As a result, the research provides an in-depth analysis that largely concentrates on the global market for facial implants’ regional development. Exact forecasts of market growth at the global, regional, and country levels are also included in the research. Strength is provided.

Key Companies Profiled

  • Stryker Corporation
  • KLS Martin Group
  • Depuy Synthes (Johnson & Johnson)
  • Zimmer Biomet Holdings, Inc
  • Osteomed L.P
  • Medartis AG
  • Integra Lifesciences
  • Matrix Surgical USA
  • Calavera Surgical Design
  • B. Braun Melsungen AG

Competitive Landscape

New product and technology introductions are a priority for industry players in the global Facial Implant Market. Additional functions include the ease of acquisition, maintenance and management, and enabling services to be scaled up or down as demands evolve. In order to strengthen their position in the worldwide Facial Implant Market, organizations are focused on industry collaborations, mergers & acquisitions, and partnerships.

The research offers a comprehensive competition analysis of some top competitors in the facial implant market, including company biographies, recent developments, and significant market strategies. It shows how the competitors are taking advantage of the opportunities present in the facial implant market.

    • In May 2022, Zimmer Biomet Holdings, Inc, a global medical technology leader, introduced the availability of new artificial intelligence (AI) capabilities within Omni&trade Suite, an intelligent operating room (OR) designed to optimize surgical workflow and procedural efficiency by automating manual tasks and streamlining unnecessary technology and redundant hardware. The new AI feature uses cameras to automatically recognize and timestamp key OR workflow milestones, including patient entry and exit, door count, the start and stop of anesthesia, surgery and cleaning. Surgical teams are guided through a process to help optimize OR workflow based on real-time access to workflow metrics.
    • In February 2022, Bactiguard and Zimmer Biomet announced to expand their global license arrangement which began in 2019, to encompass a variety of implant product segments to prevent post operative infections, joint reconstruction, implant for sports medicine, thoracic, and craniomaxillofacial applications are included in the exclusive license agreement

Related Posts

© 2023 The Tribune City - Theme by WPEnjoy · Powered by WordPress